Stock News

Results from Ongoing CANOPY Clinical Program for VOXZOGO Showcase Impact of C-Type Natriuretic Peptide (CNP) as Master Regulator of Growth-Related Development Across Multiple Genetic Skeletal Conditions New Data Highlight Meaningful Improvements in Health-Related Quality of Life for Children with Achondroplasia Investigator-Led Study Shows Significant Increases in Bone Length While Maintaining Bone Strength in Children with…

Welcome to the World of Drone Technology and AI-Powered Landmine Detection Introduction SpotlightAI™, powered by Amazon Web Services (AWS), is a cloud-based platform that revolutionizes the way we detect, locate, and map landmines and unexploded ordnance (UXO) using advanced machine learning algorithms. The company behind this groundbreaking technology, Safe Pro Group Inc., has recently received…

Awakn Life Sciences Corp. Announces Increase in Financing and Closing of Fourth Tranche Introduction Toronto, Ontario–(Newsfile Corp. – September 18, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol…

If you are a Spire Global, Inc. Investor, Here’s What You Need to Know Introduction Investing in the stock market comes with its ups and downs. If you have recently suffered a loss on your Spire Global, Inc. (NYSE:SPIR) investment, you may be wondering if there is any potential for recovery under federal securities laws….

Potential Recovery for Extreme Networks, Inc. Investors New York, NY / ACCESSWIRE / September 18, 2024 If you suffered a loss on your Extreme Networks, Inc. (NASDAQ:EXTR) investment and want to learn about a potential recovery under the federal securities laws, you may be eligible for compensation. Investors who have incurred losses on their investments…

Exciting Updates from TG Therapeutics, Inc. at ECTRIMS 2024 Infusion Related Reactions with BRIUMVI Recently presented data from the ENHANCE Phase 3b trial by TG Therapeutics, Inc. showcased the mild (Grade 1) infusion-related reactions experienced by patients receiving 30-minute BRIUMVI infusions. These reactions were found to resolve completely, highlighting the safety profile of this treatment….

Expected to Create Industry Powerhouse with Total Revenue Anticipated to Exceed $400 Million Powerfleet, Inc. Announces Strategic Acquisition of Fleet Complete Powerfleet, Inc. (Nasdaq: AIOT) has made a significant move in the mobile asset industry with the announcement of its acquisition of Fleet Complete. This strategic acquisition is expected to propel Powerfleet into becoming an…

Class Action Lawsuit Filed Against Orthofix Medical Inc. and SeaSpine Holdings Corporation New York City, NY / ACCESSWIRE / September 18, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ:OFIX) and certain current…